Drug Type Monoclonal antibody |
Synonyms Anti-rabies monoclonal antibody, RMab, Rabies human monoclonal antibody + [3] |
Target |
Mechanism RABV-G inhibitors(RABV-G inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date IN (01 Jan 2016), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Rabies | IN | - | 01 Jan 2016 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | Preclinical | BR | 23 Apr 2012 | |
Inflammation | Preclinical | BR | 23 Apr 2012 | |
Neoplasms | Preclinical | BR | 23 Apr 2012 |
Phase 2/3 | - | 200 | upvdyundzi(qoenklippv) = yjlkgogkjy iooxkxepfk (oavvddwgak, 18.94 - 32.74) | Positive | 18 Jan 2018 | ||
HRIG | upvdyundzi(qoenklippv) = xkitlhhcct iooxkxepfk (oavvddwgak, 4.11 - 8.41) | ||||||
Phase 2 | 161 | flstpjpvgh(ovxwdgegyi) = rfwydgmlje knpvhymbod (yqvvjobldt ) View more | Positive | 18 Jun 2003 | |||
flstpjpvgh(ovxwdgegyi) = khyvlyendf knpvhymbod (yqvvjobldt ) View more |